Studies in a variety of cancer cell lines also support the notion that loss of the genes encoding IFN-α/β is a frequent event, though co-deletion of p16INK4a and/or p14ARF must be specifically examined [87–89]. This evidence concerns the gene CDKN2A and cancer.